Patent Assignment
Reel/Frame 041983/0788
Assignment of Assignor's Interest
Recorded: 2017-04-12
Pages: 6
Assignor
MALLINCKRODT CRITICAL CARE FINANCE INC.
Executed: 2017-04-11
Assignee
MALLINCKRODT PHARMA IP TRADING D.A.C.
DAMASTOWN INDUSTRIAL ESTATE, MULHUDDART, DUBLIN, 15, IRELAND
Covered Properties
(3)
Method of Treating Patients with Hepatorenal Syndrome Type 1
Patent:
10,335,452 →
Application:
14/920,392 →
Publication:
US 2016/0113994
PCT:
PCT/US2015/056861 ↗
Method of Treating Patients With Hepatorenal Syndrome Type 1
Application:
62/068,357 →
Method of Treating Patients With Hepatorenal Syndrome Type 1
Application:
62/151,384 →
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 8, 2015
From: JAMIL, KHURRAM; PAPPAS, STEPHEN CHRIS; POTENZIANO, JIM
To: IKARIA THERAPEUTICS LLC
Reel/Frame 035359/0040 →
Security Interest
Apr 19, 2015
From: IKARIA THERAPEUTICS LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 035443/0241 →
Assignment of Assignor's Interest
Jun 19, 2015
From: JAMIL, KHURRAM; PAPPAS, STEPHEN CHRIS; POTENZIANO, JIM
To: IKARIA THERAPEUTICS LLC
Reel/Frame 035936/0714 →
Assignment of Assignor's Interest
Apr 12, 2017
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 041983/0885 →
Assignment of Assignor's Interest
Apr 12, 2017
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 041983/0946 →
Assignment of Assignor's Interest
Apr 12, 2017
From: JAMIL, KHURRAM; PAPPAS, STEPHEN CHRIS; POTENZIANO, JIM
To: IKARIA THERAPEUTICS LLC
Reel/Frame 042234/0295 →
Merger
Apr 12, 2017
From: IKARIA THERAPEUTICS LLC
To: MALLINCKRODT HOSPITAL PRODUCTS INC.
Reel/Frame 041983/0509 →
Assignment of Assignor's Interest
Apr 12, 2017
From: MALLINCKRODT HOSPITAL PRODUCTS INC.
To: THERAKOS, INC.
Reel/Frame 041983/0632 →
Assignment of Assignor's Interest
Apr 12, 2017
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 041983/0680 →
Notice of Grant of Security Interest in Patents
Aug 18, 2017
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 043601/0025 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 035443, Frame 0241
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0930 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Patent Security Interests Recorded at Reel 043601, Frame 0025
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0233 →
Security Interest
Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →
Security Interest
Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
Corrective Assignment to Correct the Inclusion of Us Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 72331 Frame 1. Assignor(S) Hereby Confirms the Security Interest.
Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
Corrective Assignment to Correct the Inclusion of Us Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 73375 Frame 395. Assignor(S) Hereby Confirms the Security Interest.
Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →